Abstract
The release of cytoplasmic heart fatty acid-binding protein (H-FABP) into the plasma of cardiac patients up to 38 hr after the onset of the first clinical symptoms of acute myocardial infarction (AMI) was studied, using a sensitive direct and noncompetitive Enzyme Linked Immunosorbent Assay of the antigen capture type (sandwich ELISA), newly developed for the measurement of small amounts of human H-FABP in plasma samples. Plasma levels of H-FABP were compared with plasma activity levels of the myocardial cytoplasmic enzymes creatine kinase MB (CK-MB) and alpha-hydroxybutyrate dehydrogenase (α-HBDH). Upper normal levels of H-FABP (19μg/l), CK-MB (10 U/l) and α-HBDH (160 U/l) as determined in plasma from 72 blood donors served as threshold levels. H-FABP levels were significantly elevated above their threshold level within 3 hr after AMI. Peak levels of H-FABP, CK-MB and α-HBDH were reached 4.1 ± 0.9 hr, 8.4 ± 1.4 hr and 25.0 ± 9.5 hr (means ± S.D., n = 10) after acute myocardial infarction, respectively. Serial time curves of the plasma contents of H-FABP reveal that after myocardial infarction H-FABP is released in substantial amounts from human hearts. In 18 out of 22 patients with established AMI the plasma FABP level was at or above the threshold level in blood-samples taken within 3.5 hr after the first onset of symptoms of AMI, while for CK-MB this applied to 9 patients and for α-HBDH to 6 patients. These findings suggest that for an early indication of acute myocardial infarction in man cytoplasmic heart fatty acid-binding protein is more suitable than heart type creatine kinase MB and/or alpha-hydroxybutyrate dehydrogenase. (Mol Cell Biochem116: 155–162,1992)
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- H-FABP:
-
(cytoplasmic) Heart Fatty Acid-Binding Protein
- LDH:
-
Lactate Dehydrogenase, α-HBDH-α-Hydroxybutyrate Dehydrogenase
- CK-MB:
-
Creatine Kinase-MB
- AMI:
-
Acute Myocardial Infarction
- PBS:
-
Phosphate Buffered Saline
- BSA:
-
Bovine Serum Albumin
References
Glatz JFC, Van der Vusse GJ: Cellular fatty acid-binding proteins: Current concepts and future directions. Mol Cell Biochem 98:237–251,1990
Bass NM: The cellular fatty acid binding proteins: Aspects of structure, regulation, and function. Int Rev Cytol 111: 143–184, 1988
Veerkamp JH, Peeters RA, Maatman RGHJ: Structural and functional features of different types of cytoplasmic fatty acidbinding proteins. Biochim Biophys Acta 1081: 1–24, 1991
Glatz JFC, van Bilsen M, Paulussen RJA, Veerkamp JH, van der Vusse GJ, Reneman RS: Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochim Biophys Acta 961: 148–152, 1988
Knowlton AA, Apstein CS, Saouf R, Brecher P: Leakage of heart fatty acid binding protein with ischemia and reperfusion in the rat. J Mol Cell Cardiol 21: 577–583, 1989
Knowlton AA, Burrier RE, Brecher P: Rabbit heart fatty acidbinding protein: Isolation, characterization, and application of a monoclonal antibody. Circ Res 65: 981–998, 1989
Tanaka T, Hirota Y, Sohmiya K-I, Nishimura S, Kawamura K: Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction. Clin Biochem 24: 195–201, 1991
Ingelfinger JA, Mosteller F, Thibodeau LA, Ware JH. In: Biostatistics in clinical medicine. MacMillan Publishing Co., Inc., New York, 1983, pp 85–113
Kleine AH, Glatz JFC, van Nieuwenhoven FA, Vallinga MIJ, Salden MHL, Bosman FT, Boersma WJA, Zegers ND, Van der Vusse GJ: Type-specific immunodetection of human heart fatty acid-binding protein with polyclonal anti-peptide antibodies. Mol Cell Biochem 98: 41–48, 1990
Glatz JFC, Veerkamp JH: A radiochemical procedure for the assay of fatty acid binding by proteins. Anal Biochem 132: 89–95, 1983
Wilson MB, Nakane PK. In: W Knapp, K. Holubar, G Wick (eds) Immunofluorescence and Related Techniques. Elsevier/ North-Holland, Amsterdam, 1978, pp215–224
Börchers T, Unterberg C, Rüdel H, Robenek H, Spener F: Subcellular distribution of cardiac fatty acid-binding protein in bovine heart muscle and quantitation with an enzyme-linked immunosorbent assay. Biochim Biophys Acta 1002: 54–61, 1989
Rosalki SB, Wilkinson JH: Reduction of alpha-ketobutyrate by human serum. Nature 188: 1110–1111, 1960
Peeters RA, Veerkamp JH, Kanda T, Ono T, Van Kessel AD: Cloning of the cDNA encoding human skeletal muscle fatty acid-binding protein, its peptide sequence and chromosomal localization. Biochem J 276: 203–207, 1991
Waldman TA, Strauber W, Mogielnicki RP: The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with proteinuria, the nephrotic syndrome, or uremia. J Clin Invest 51: 2162–2174, 1972
Hall CL, Hardwicke J: Low molecular weight proteinuria. Ann Rev Med 30: 199–211, 1979
Klocke FJ, Copley DP, Krawczyk JA, Reichlin M: Rapid renal clearance of immunoreactive canine plasma myoglobin. Circulation 65: 1522–1528, 1982
Stone MJ, Waterman MR, Harimoto D, Murray G, Wilson N, Platt MR, Blomqvist G, Willerson JT: Serum myoglobin level as diagnostic test in patients with acute myocardial infarction. Br Heart J 39: 375–380, 1977
Varki AP, Roby DS, Watts H, Zatuchni J: Serum myoglobin in acute myocardial infarction: A clinical study and review of the literature. Am Heart J 96: 680–688, 1978
Drexel H, Dworzak E, Kirchmair W, Milz MM, Puschendorf B, Dienstl F: Myoglobinemia in the early phase of acute myocardial infarction. Am Heart J 105: 642–651, 1983
McComb JM, McMaster EA, MacKenzie G, Adgey AAJ: Myoglobin and creatine kinase in acute myocardial infarction. Br Heart J 51: 189–194, 1984
Isakov A, Shapira I, Burke M, Almog C: Serum myoglobin levels in patients with ischemic myocardial insult. Arch Intern Med 148: 1762–1765, 1988
Ellis AK, Saran BR: Kinetics of myoglobin release and prediction of myocardial depletion after coronary artery reperfusion. Circulation 80: 676–683, 1989
Ohman EM, Casey C, Bengtson JR, Pryor D, Tormey WA, Horgan JH: Early detection of acute myocardial infarction: additional diagnostic information from serum concentrations of myoglobin in patients without ST elevation. Br Heart J 63: 335–338,1990
Driessen-Kletter MF, Amelink GJ, Bär PR, van Gijn J: Myoglobin is a sensitive marker of increased muscle membrane vulnerability. J Neurol 237: 234–238, 1990
Sylvén C, Jansson E, Böör K: Myoglobin content in human skeletal muscle and myocardium: relation to fibre size and oxidative capacity. Cardiovasc Res 18: 443–446, 1984
Lin L, Sylvén C, Sotonyi P, Somogyi E, Kaijser L, Jansson E: Myoglobin content and citrate synthase activity in different parts of the normal human heart. J Appl Physiol 69: 899–901, 1990
Paulussen RJA, Van Moerkerk HTB, Veerkamp JH: Immunochemical quantitation of fatty acid-binding proteins. Tissue distribution of liver and heart FABP types in human and porcine tissues. Int J Biochem 22: 393–398, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kleine, A.H., Glatz, J.F.C., Van Nieuwenhoven, F.A. et al. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 116, 155–162 (1992). https://doi.org/10.1007/BF01270583
Issue Date:
DOI: https://doi.org/10.1007/BF01270583